Last Updated: October 3, 2025
Analyzing Management
For hedge funds and asset managers, the quality of public company leadership plays a pivotal role in both early due diligence and continuous risk assessment. ManagementTrack offers a consistent methodology that filters out distractions, highlighting core strengths and vulnerabilities, flagging potential issues, and drawing a straightforward connection between CEO choices and financial performance.
CEO Carestio’s record poised to convert backlog and navigate cost pressures.
Analysis of STERIS CEO Daniel Carestio
With a proven record of driving growth across key segments and protecting margins, Daniel Carestio is well-positioned to execute on STERIS’s backlog conversion and navigate near-term market and cost pressures.
Management evaluated Daniel Carestio’s track record and skillset against the following key factors for STE:
- Converting $111M Life Sciences backlog to re-ignite growth.
- Maintaining AST’s double-digit growth amid market uncertainty.
- Sustaining Healthcare momentum to capitalize on market share gains.
- Offsetting $45M tariff headwind to protect margins.
Daniel Carestio’s Track Record & Key Open Questions to Research
ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.
Question #1
Given the Dental segment’s failure, how does Carestio balance his proven operational ability to integrate a business against the strategic discipline required to walk away from a flawed deal in the first place?
Question #2
Reflecting on the historical EtO safety violations in his former division, does Carestio’s leadership style prioritize achieving near-term financial targets over making the difficult, costly investments required to mitigate long-tail operational and regulatory risks?
Why Do Investors Use ManagementTrack?
How does ManagementTrack evaluate STE’s CEO, Daniel Carestio?
ManagementTrack evaluates Daniel Carestio by conducting proprietary career analysis and interviewing former colleagues to build a detailed picture of his track record, key strengths, and weaknesses. This profile is then measured against STE’s most critical priorities, including: converting the large Life Sciences backlog to re-ignite growth, maintaining AST’s double-digit expansion amid market uncertainty, sustaining Healthcare’s momentum to capitalize on recent market share gains, and offsetting major tariff headwinds to protect margins.
Beyond career analysis, what methods does ManagementTrack use to link executive leadership to future results?
ManagementTrack utilizes a suite of proprietary tools to forecast company performance. Its models are designed to flag instances of executive evasion in earnings call Q&A and gauge whether such behavior is unusual. ManagementTrack also scrutinizes all insider transactions to pinpoint outliers predictive of future stock movements. These elements are synthesized into the ManagementTrack Rating, a predictive 1-10 score for every executive, giving investors a clear, actionable view on the expected impact of management on a company’s future.
What is the scope of ManagementTrack’s coverage?
ManagementTrack offers real-time coverage that extends to the complete C-suite of every publicly listed company.
How to Learn More
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.
Author
Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.
Sources
- Verified Career History by ManagementTrack for Daniel Carestio
- Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
- STERIS Plc (Ireland) 10Q
- STERIS Plc (Ireland) 10K
- STERIS Plc (Ireland) Earnings Calls
- STERIS Plc (Ireland) Press Releases
Relevant Links
- For more information on ManagementTrack’s Data visit: https://paragonintel.com/management-track-data/
- For more information on ManagementTrack’s Interview & Analysis visit: https://paragonintel.com/management-track-reports/
- For more information on ManagementTrack’s Interview library visit: https://paragonintel.com/management-track-report-library/
- For more information on ManagementTrack’s Evasion Analysis visit: https://paragonintel.com/earnings-call-evasion/
- For more information on how ManagementTrack helps hedge funds and asset managers visit: https://paragonintel.com/
